Wayne Weisman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Wayne Weisman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Wayne Weisman. Wayne Weisman is Director in Recro Pharma, Inc. ($REPH) and in ReWalk Robotics Ltd. ($RWLK) and Director in ReWalk Robotics Ltd. ($RWLK) and Director in Baudax Bio, Inc. ($BXRX).
Latest Insider Trading Transactions of Wayne Weisman
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BXRX, REPH, RWLK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
Apr 22 2021 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 26,923 | 0 | 84,982 | 58.1 K to 85 K (+46.37 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 56,452 | 0 | 119,985 | 63.5 K to 120 K (+88.85 %) |
Jul 07 2020 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Grant | A | 0.00 | 10,948 | 0 | 76,760 | 65.8 K to 76.8 K (+16.64 %) |
May 11 2020 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
May 11 2020 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 8,363 | 0 | 58,059 | 49.7 K to 58.1 K (+16.83 %) |
May 08 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Option Exercise | A | 3.05 | 34,574 | 105,451 | 34,574 | |
May 08 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 22,951 | 0 | 63,533 | 40.6 K to 63.5 K (+56.55 %) |
Mar 27 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Buy | P | 2.29 | 10,000 | 22,900 | 40,582 | 30.6 K to 40.6 K (+32.70 %) |
Mar 27 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Buy | P | 2.29 | 10,000 | 22,900 | 40,582 | 30.6 K to 40.6 K (+32.70 %) |
Dec 09 2019 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 15,284 | 0 | 49,696 | 34.4 K to 49.7 K (+44.41 %) |
Dec 09 2019 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 20,000 | 0 | 30,582 | 10.6 K to 30.6 K (+189.00 %) |
Mar 28 2019 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Grant | A | 0.00 | 116,496 | 0 | 145,245 | 28.7 K to 145.2 K (+405.22 %) | |
May 14 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
May 14 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | M | 0.00 | 13,274 | 0 | 26,457 | 13.2 K to 26.5 K (+100.69 %) |
May 08 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
May 08 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 6,183 | 0 | 13,183 | 7 K to 13.2 K (+88.33 %) |
May 02 2018 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Grant | A | 0.00 | 22,727 | 0 | 28,749 | 6 K to 28.7 K (+377.40 %) |
Jun 29 2017 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Option Exercise | A | 2.10 | 4,176 | 8,770 | 4,176 | |
Jun 28 2017 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 3.09 | 49,970 | 154,562 | 1,500,100 | 1.6 M to 1.5 M (-3.22 %) |
Jun 28 2017 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 3.00 | 37,030 | 111,090 | 1,550,070 | 1.6 M to 1.6 M (-2.33 %) |
May 16 2017 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 0.00 | 13,274 | 0 | 13,274 | |
Dec 19 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | P | 6.57 | 3,000 | 19,710 | 7,000 | 4 K to 7 K (+75.00 %) |
Dec 19 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | P | 6.53 | 4,000 | 26,120 | 4,000 | 0 to 4 K |
Aug 17 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 6.29 | 50,000 | 314,605 | 1,587,100 | 1.6 M to 1.6 M (-3.05 %) |
Aug 17 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 6.42 | 6,235 | 40,037 | 1,637,100 | 1.6 M to 1.6 M (-0.38 %) |
Aug 17 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 6.45 | 43,765 | 282,210 | 1,643,335 | 1.7 M to 1.6 M (-2.59 %) |
Jun 06 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 7.90 | 5,289 | 41,762 | 1,687,100 | 1.7 M to 1.7 M (-0.31 %) |
Jun 06 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 7.89 | 13,771 | 108,668 | 1,692,389 | 1.7 M to 1.7 M (-0.81 %) |
Jun 02 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 7.58 | 6,270 | 47,519 | 1,706,160 | 1.7 M to 1.7 M (-0.37 %) |
Jun 02 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 7.94 | 5,100 | 40,499 | 1,712,430 | 1.7 M to 1.7 M (-0.30 %) |
May 27 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 8.61 | 15,000 | 129,107 | 1,717,530 | 1.7 M to 1.7 M (-0.87 %) |
May 27 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 8.80 | 12,022 | 105,760 | 1,732,530 | 1.7 M to 1.7 M (-0.69 %) |
May 26 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Option Exercise | A | 8.70 | 4,176 | 36,331 | 4,176 | |
May 25 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 8.95 | 200 | 1,790 | 1,744,552 | 1.7 M to 1.7 M (-0.01 %) |
May 25 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 9.00 | 1,200 | 10,800 | 1,744,752 | 1.7 M to 1.7 M (-0.07 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.45 | 5,008 | 32,326 | 778,634 | 783.6 K to 778.6 K (-0.64 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.45 | 14,992 | 96,770 | 2,330,321 | 2.3 M to 2.3 M (-0.64 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.46 | 1,252 | 8,083 | 783,642 | 784.9 K to 783.6 K (-0.16 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 6.46 | 3,748 | 24,197 | 2,345,313 | 2.3 M to 2.3 M (-0.16 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 150 | 1,350 | 784,894 | 785 K to 784.9 K (-0.02 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 450 | 4,050 | 2,349,061 | 2.3 M to 2.3 M (-0.02 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 2,250 | 20,252 | 785,044 | 787.3 K to 785 K (-0.29 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 6,737 | 60,639 | 2,349,511 | 2.4 M to 2.3 M (-0.29 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 1,553 | 13,977 | 787,294 | 788.8 K to 787.3 K (-0.20 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 4,648 | 41,832 | 2,356,248 | 2.4 M to 2.4 M (-0.20 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.01 | 691 | 6,223 | 788,847 | 789.5 K to 788.8 K (-0.09 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.01 | 2,068 | 18,624 | 2,360,896 | 2.4 M to 2.4 M (-0.09 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 3,702 | 33,321 | 789,538 | 793.2 K to 789.5 K (-0.47 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Sell | S | 9.00 | 11,082 | 99,748 | 2,362,964 | 2.4 M to 2.4 M (-0.47 %) |
May 23 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 9.08 | 11,148 | 101,210 | 1,745,952 | 1.8 M to 1.7 M (-0.63 %) |
May 23 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 9.12 | 5,000 | 45,595 | 1,757,100 | 1.8 M to 1.8 M (-0.28 %) |
Mar 09 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 8.33 | 3,002 | 25,007 | 1,762,100 | 1.8 M to 1.8 M (-0.17 %) |
Mar 07 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 8.50 | 1,998 | 16,983 | 1,765,101 | 1.8 M to 1.8 M (-0.11 %) |
Mar 07 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 8.80 | 5,001 | 44,009 | 1,767,099 | 1.8 M to 1.8 M (-0.28 %) |
Jan 20 2016 | RWLK | ReWalk Robotics Lt ... | Weisman Wayne | Director | Sell | S | 10.30 | 50,000 | 514,840 | 1,772,100 | 1.8 M to 1.8 M (-2.74 %) |
Dec 18 2015 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 8.41 | 10,000 | 84,100 | 10,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | C | 5.00 | 1,875,000 | 9,375,000 | 0 | |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 8.00 | 20,000 | 160,000 | 20,000 | |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | C | 0.00 | 2,045,738 | 0 | 3,167,286 | 1.1 M to 3.2 M (+182.40 %) |
Mar 13 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | C | 0.00 | 1,121,548 | 0 | 1,121,548 | 0 to 1.1 M |
Page: 1